FCCC LOGO Faculty Publications
New protein structures provide an updated understanding of phenylketonuria
Mol Genet Metab. 2017 Jun 15;121(4) :289-296
PMID: 28645531    PMCID: PMC5549558    URL: https://www.ncbi.nlm.nih.gov/pubmed/28645531
Back to previous list
Abstract
Phenylketonuria (PKU) and less severe hyperphenylalaninemia (HPA) constitute the most common inborn error of amino acid metabolism, and is most often caused by defects in phenylalanine hydroxylase (PAH) function resulting in accumulation of Phe to neurotoxic levels. Despite the success of dietary intervention in preventing permanent neurological damage, individuals living with PKU clamor for additional non-dietary therapies. The bulk of disease-associated mutations are PAH missense variants, which occur throughout the entire 452 amino acid human PAH protein. While some disease-associated mutations affect protein structure (e.g. truncations) and others encode catalytically dead variants, most have been viewed as defective in protein folding/stability. Here we refine this view to address how PKU-associated missense variants can perturb the equilibrium among alternate native PAH structures (resting-state PAH and activated PAH), thus shifting the tipping point of this equilibrium to a neurotoxic Phe concentration. This refined view of PKU introduces opportunities for the design or discovery of therapeutic pharmacological chaperones that can help restore the tipping point to healthy Phe levels and how such a therapeutic might work with or without the inhibitory pharmacological chaperone BH4. Dysregulation of an equilibrium of architecturally distinct native PAH structures departs from the concept of "misfolding", provides an updated understanding of PKU, and presents an enhanced foundation for understanding genotype/phenotype relationships.
Notes
1096-7206 Jaffe, Eileen K P30 CA006927/CA/NCI NIH HHS/United States Journal Article Review United States Mol Genet Metab. 2017 Jun 15. pii: S1096-7192(17)30361-X. doi: 10.1016/j.ymgme.2017.06.005.